Patents by Inventor Lars Bendtsen

Lars Bendtsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230026692
    Abstract: A method (300) of operating a hearing aid with a low delay beam former and a hearing aid (200, 500).
    Type: Application
    Filed: December 4, 2020
    Publication date: January 26, 2023
    Applicant: Widex A/S
    Inventors: Rasmus BENDTSEN, Lars Dalskov, Pejman MOWLAEE, Jacob Thorup HALD, Jannik Thorup ANDERSEN, Thomas Bo ELMEDYB, Georg STIEFENHOFER, Adam WESTERMANN, Michael Johannes PIHL, Nanna Moeller PEDERSEN
  • Patent number: 11207330
    Abstract: Mirtazapine is useful for the treatment and/or prophylaxis of medication overuse headache based on tension-type headache. Moreover, a pharmaceutical composition and/or the use of mirtazapine for the manufacture of a medicament, are useful against medication overuse headache based on tension-type headache, and the treatment of medication overuse headache based on tension-type headache.
    Type: Grant
    Filed: October 1, 2020
    Date of Patent: December 28, 2021
    Assignees: Curatis AG, Rigshospitalet—Glostrup, The University of Copenhagen
    Inventors: Arnim Pause, Lars Bendtsen, Rigmor Jensen, Jes Olesen
  • Publication number: 20210015828
    Abstract: Mirtazapine is useful for the treatment and/or prophylaxis of medication overuse headache based on tension-type headache. Moreover, a pharmaceutical composition and/or the use of mirtazapine for the manufacture of a medicament, are useful against medication overuse headache based on tension-type headache, and the treatment of medication overuse headache based on tension-type headache.
    Type: Application
    Filed: October 1, 2020
    Publication date: January 21, 2021
    Applicants: Curatis AG, Rigshospitalet - Glostrup, The University of Copenhagen
    Inventors: Arnim PAUSE, Lars Bendtsen, Rigmor Jensen, Jes Olesen
  • Publication number: 20040097562
    Abstract: NMDA receptor antagonists, especially mirtazapine, can be used to treat tension-type headaches.
    Type: Application
    Filed: November 7, 2003
    Publication date: May 20, 2004
    Inventors: Jes Olesen, Lars Bendtsen, Rigmor Jensen, Ulf Madsen
  • Publication number: 20040048860
    Abstract: This invention relates to the use of selective noradrenaline reuptake inhibitors, in particular reboxetine, for the treatment of tension-type headache.
    Type: Application
    Filed: August 6, 2003
    Publication date: March 11, 2004
    Inventors: Jes Olesen, Rigmor Jensen, Lars Bendtsen
  • Patent number: 6649605
    Abstract: NMDA receptor antagonists, especially mirtazapine, can be used to treat tension-type headaches.
    Type: Grant
    Filed: August 30, 2001
    Date of Patent: November 18, 2003
    Assignee: Head Explorer A/S
    Inventors: Jes Olesen, Lars Bendtsen, Rigmor Jensen, Ulf Madsen
  • Publication number: 20020072543
    Abstract: Tension-type headache is treated by interacting smith neuronal transmission in relation to pain in connection with headache in a way which prevents or decreases sensitization of second order nociceptive neurons. In particular, treatment is performed by administration of an effective amount of a substance which prevents or decreases central sensitization. Important examples of such substances are substances which interact with glutamate neurotransmission, such as glutamate receptor antagonists, such as NMDA receptor antagonists, such as MK-801 or Amitriptylline or Imipramine or Desipramine or Mirtazaprine or Venlafaxine. Other examples are substances which interact with nitric oxide, such as nitric oxide synthase (NOS) inhibitors, such as L-NMMA or L-NAME or L-NIO or L-NNA.
    Type: Application
    Filed: August 30, 2001
    Publication date: June 13, 2002
    Inventors: Jes Olesen, Lars Bendtsen, Rigmor Jensen, Ulf Madsen
  • Patent number: 6284794
    Abstract: Tension-type headache is treated by interacting with neuronal transmission in relation to pain in connection with headache in a way which prevents or decreases sensitization of second order nociceptive neurons. In particular, treatment is performed by administration of an effective amount of a substance which prevents or decreases central sensitization. Important examples of such substances are substances which interact with nitric oxide, such as nitric oxide synthase (NOS) inhibitors, such as L-NMMA or L-NAME or L-NIO or L-NNA. According to a broader aspect of the invention tension-type headache is treated by administration of substances which are effective in preventing or decreasing pain in connection with tension-type headache, such as the substances mentioned above.
    Type: Grant
    Filed: May 4, 1999
    Date of Patent: September 4, 2001
    Assignee: Head Explorer APS
    Inventors: Jes Olesen, Lars Bendtsen, Rigmor Jensen, Ulf Madsen